John R Fischer

PE delves into diverse women’s health segments: 6 deals

Ardian, Charterhouse, CVC and L Catterton are among the PE firms investing in different areas of the women's healthcare market.

Riverglade-backed Dynamic Access acquires Picc Stat

Minneapolis-based Picc Stat is a family-owned vascular access services provider.

Chicago Pacific Founders invests in Nexben

Based in Minneapolis, Nexben is a provider of end-to-end healthcare benefits management and consultation services.

Astorg, EQT, TA, New Mountain active in pharma ingredients; Medical components manufacturing draws in dealmakers

A look at the active pharmaceutical ingredients (API) sector, which has attracted the likes of Astorg, EQT, TA Associates and New Mountain Capital; an agreement by American Securities to sell a medical components manufacturer; insights learned from advisory services firm BDO about the life sciences IPO and M&A market.

PE eyes growth opportunities in active pharmaceutical ingredients: 5 deals

Astorg, EQT, New Mountain Capital and TA Associates are among the PE firms buying and selling active pharmaceutical ingredient assets.

Kinderhook, Renovus, Revelstoke eye hospice care; QC Capital invests in pediatric telemedicine

Earlier this week, QC Capital Group announced an investment in My Pediatric Doctor, a US-based urgent care pediatric telemedicine company.

PE eyes growth in hospice care platforms: 5 deals

Kinderhook, Renovus and Revelstoke are among the PE firms pursuing investments in the hospice care market.

PE bullish on medical component manufacturing: 5 deals

Avista, MidEuropa, SK Capital and Sheridan Capital are among the PE firms investing in medical component manufacturing.

How healthcare labor shortages are driving PE investments in medical education

'Healthcare education generally is an industry that is not very professionalized. So, when you have new PE buyers coming in, a lot of time and effort is spent scaling up and professionalizing operations,' said Charterhouse's Pierre de Sarrau.

Last chance to nominate Women in PE; Antin, Arcline, Carlyle pursue heart health

The growing prevalence of heart-related issues is driving demand in cardiological care, and in turn, getting interest from private equity firms such as Antin, Arcline and Carlyle; growing regulatory support and biotech company growth are drawing private equity to regenerative medicine; healthcare investors saw wins in the fourth quarter.